Literature DB >> 20677944

Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States.

Christine N Dao1, Laurie Kamimoto, Mackenzie Nowell, Arthur Reingold, Ken Gershman, James Meek, Kathryn E Arnold, Monica Farley, Patricia Ryan, Ruth Lynfield, Craig Morin, Joan Baumbach, Emily Hancock, Shelley Zansky, Nancy M Bennett, Ann Thomas, Meredith Vandermeer, David L Kirschke, William Schaffner, Lyn Finelli.   

Abstract

BACKGROUND: Rates of influenza-associated hospitalizations in the United States have been estimated using modeling techniques with data from pneumonia and influenza hospitalization discharge diagnoses, but they have not been directly estimated from laboratory-positive cases.
METHODS: We calculated overall, age-specific, and site-specific rates of laboratory-positive, influenza-associated hospitalization among adults and compared demographic and clinical characteristics and outcomes of hospitalized cases by season with use of data collected by the Emerging Infections Program Network during the 2005-2006 through 2007-2008 influenza seasons.
RESULTS: Overall rates of adult influenza-associated hospitalization per 100,000 persons were 9.9 during the 2005-2006 season, 4.8 during the 2006-2007 season, and 18.7 during the 2007-2008 season. Rates of hospitalization varied by Emerging Infections Program site and increased with increasing age. Higher overall and age-specific rates of hospitalization were observed during influenza A (H3) predominant seasons and during periods of increased circulation of influenza B. More than 80% of hospitalized persons each season had > or =1 underlying medical condition, including chronic cardiovascular and metabolic diseases.
CONCLUSIONS: Rates varied by season, age, geographic location, and type/subtype of circulating influenza viruses. Influenza-associated hospitalization surveillance is essential for assessing the relative severity of influenza seasons over time and the burden of influenza-associated complications.

Entities:  

Mesh:

Year:  2010        PMID: 20677944     DOI: 10.1086/655904

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

1.  Estimating the Effect of Influenza Vaccination on Nursing Home Residents' Morbidity and Mortality.

Authors:  Aurora Pop-Vicas; Momotazur Rahman; Pedro L Gozalo; Stefan Gravenstein; Vincent Mor
Journal:  J Am Geriatr Soc       Date:  2015-08-17       Impact factor: 5.562

2.  Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies.

Authors:  Dominic E Dwyer
Journal:  Vaccine       Date:  2011-07-22       Impact factor: 3.641

3.  Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.

Authors:  Marc Lipsitch; Lyn Finelli; Richard T Heffernan; Gabriel M Leung; Stephen C Redd
Journal:  Biosecur Bioterror       Date:  2011-06

Review 4.  Infection in severe asthma exacerbations and critical asthma syndrome.

Authors:  Christian E Sandrock; Andrew Norris
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

5.  Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season.

Authors:  Fiona Havers; Brendan Flannery; Jessie R Clippard; Manjusha Gaglani; Richard K Zimmerman; Lisa A Jackson; Joshua G Petrie; Huong Q McLean; Mary Patricia Nowalk; Michael L Jackson; Arnold S Monto; Edward A Belongia; Heather F Eng; Lois Lamerato; Angela P Campbell; Alicia M Fry
Journal:  Clin Infect Dis       Date:  2015-02-25       Impact factor: 9.079

Review 6.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

7.  Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model.

Authors:  Jacqueline M McBride; Jeremy J Lim; Tracy Burgess; Rong Deng; Michael A Derby; Mauricio Maia; Priscilla Horn; Omer Siddiqui; Daniel Sheinson; Haiyin Chen-Harris; Elizabeth M Newton; Dimitri Fillos; Denise Nazzal; Carrie M Rosenberger; Maikke B Ohlson; Rob Lambkin-Williams; Hosnieh Fathi; Jeffrey M Harris; Jorge A Tavel
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

8.  Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8⁺ T cell response.

Authors:  Lance K Blevins; John T Wren; Beth C Holbrook; Sarah L Hayward; W Edward Swords; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

9.  Outcomes of Immunocompromised Adults Hospitalized With Laboratory-confirmed Influenza in the United States, 2011-2015.

Authors:  Jennifer P Collins; Angela P Campbell; Kyle Openo; Monica M Farley; Charisse Nitura Cummings; Mary Hill; William Schaffner; Mary Lou Lindegren; Ann Thomas; Laurie Billing; Nancy Bennett; Nancy Spina; Marisa Bargsten; Ruth Lynfield; Seth Eckel; Patricia Ryan; Kimberly Yousey-Hindes; Rachel Herlihy; Pam Daily Kirley; Shikha Garg; Evan J Anderson
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

10.  Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia.

Authors:  Ikwo K Oboho; Anna Bramley; Lyn Finelli; Alicia Fry; Krow Ampofo; Sandra R Arnold; Wesley H Self; Derek J Williams; D Mark Courtney; Yuwei Zhu; Evan J Anderson; Carlos G Grijalva; Jonathan A McCullers; Richard G Wunderink; Andrew T Pavia; Kathryn M Edwards; Seema Jain
Journal:  Open Forum Infect Dis       Date:  2016-12-27       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.